Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.

Calabrese L, Moltrasio C, Romagnuolo M, Stadler PC, Fiocco Z, Neulinger-Muñoz M, Aoki R, D'Onghia M, Rubegni P, Kerl K, Satoh TK, Marzano AV, French LE

Open source

DOI: 10.1111/exd.70323
Published: 2026 Jul
Container: Experimental dermatology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/exd.70323,
  title = {Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.},
  author = {Calabrese L and Moltrasio C and Romagnuolo M and Stadler PC and Fiocco Z and Neulinger-Muñoz M and Aoki R and D'Onghia M and Rubegni P and Kerl K and Satoh TK and Marzano AV and French LE},
  year = {2026},
  journal = {Experimental dermatology},
  doi = {10.1111/exd.70323},
  url = {https://doi.org/10.1111/exd.70323}
}

RIS

TY  - JOUR
TI  - Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.
AU  - Calabrese L
AU  - Moltrasio C
AU  - Romagnuolo M
AU  - Stadler PC
AU  - Fiocco Z
AU  - Neulinger-Muñoz M
AU  - Aoki R
AU  - D'Onghia M
AU  - Rubegni P
AU  - Kerl K
AU  - Satoh TK
AU  - Marzano AV
AU  - French LE
PY  - 2026
JO  - Experimental dermatology
DO  - 10.1111/exd.70323
UR  - https://doi.org/10.1111/exd.70323
ER  -

APA

L, C., C, M., M, R., PC, S., Z, F., M, N., R, A., M, D., P, R., K, K., TK, S., AV, M., & LE, F. (2026). Type I and II Interferon Signalling Characterizes the Transcriptional Landscape of Sweet Syndrome.. Experimental dermatology. https://doi.org/10.1111/exd.70323

Source records

pubmed · retrieved 2026-09-26T13:42:42.742Z